Boditech Media - Boditech Med

Boditech Med, Obtains Export Permit for the Biomarker 'PenKid' for Acute Kidney Injury Diagnosis

Obtained an Export Permit for PenKid, which enables a rapid diagnosis of acute kidney injury within 15 minutes

Joinstar will be supplied with key components of cartridges used in chronic disease diagnosis.

With a simple and safe sample collection, it can detect COVID-19 antigen in 15 minutes

NEWS Performance comparison of COVID-19 Ag – JCV & FIND
Evaluation of 11 different COVID-19 Ag tests
PRESS RELEASE Boditech Med breaks ground for new R&D Center in Korea
Investing to expand new R&D Center
PRESS RELEASE Boditech Med, ichroma™/AFIAS COVID-19 nAb is approved by ANVISA in Brazil
Expecting to verify the activation of immune system after COVID-19 vaccination
NEWS Introduction of COVID-19 Neutralizing Antibody
A quick diagnostic test to monitor immune response against COVID-19
NEWS ichroma™ COVID-19 Ag Clinical evaluation results
The *FIND evaluation of ichroma™ COVID-19 Ag had been posted
NEWS AFIAS COVID-19 Ag Clinical evaluation results
The evaluation was conducted in the United States, South Korea, and Netherlands
NEWS COVID-19/Flu Ag Combo launching
Enabling to test COVID-19 and Flu simultaneously within 20mins
PRESS RELEASE Boditech Med signs about $11 million contract with EOS in Italy to supply COVID-19 antigen test kits
Bodtiech’s market dominance is getting bigger in Europe
PRESS RELEASE Boditech Med reported its highest quarterly revenue ever
Third-quarter sales 116%↑ operating profit 388%↑
NEWS Boditech Med launches ichroma™/AFIAS IL-6 (Interlukin-6)
Assessing to diagnose acute inflammatory and sepsis

6 7 8 9